The Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADT

Launched by CHINESE UNIVERSITY OF HONG KONG · Dec 1, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how a team-based approach to healthcare can help reduce cardiovascular (CV) risks in men with prostate cancer who are starting hormone therapy called androgen deprivation therapy (ADT). While ADT is effective in managing prostate cancer, it can lead to heart-related issues, especially since many patients live longer with the disease. The trial aims to find out if closely monitoring heart health and having a coordinated care team can make a positive difference for these patients.

To participate in this study, men aged 18 to 80 who have been diagnosed with prostate cancer and are planning to undergo ADT for at least one year may be eligible. However, those with certain heart conditions or recent serious heart events are not eligible to join. Participants can expect regular check-ups and support from a team of healthcare professionals focused on managing both their cancer and heart health. This study is currently recruiting participants, and it aims to improve understanding of how best to monitor and reduce cardiovascular risk in prostate cancer patients.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Adult men 18-80 years old
• • With histological proven prostate cancer or clinically diagnosed to have prostate cancer,
• • Planned for ADT for at least 1 year
• Exclusion Criteria:
• • Subjects with established major atherosclerotic cardiovascular disease (ASCVD) as defined by a recent acute coronary syndrome within the past 12 months, a history of myocardial infarction other than the recent acute coronary syndrome event, a history of ischemic stroke, and symptomatic peripheral arterial disease (defined as history of claudication with ankle-brachial index \<0.85 or previous revascularization or amputation
• • Prior neoadjuvant or adjuvant hormone therapy within 1 year before
• • Refuse or unable to give written informed consent
• • Participation in an investigational program with interventions outside of routine clinical practice